Finally, α2β1 integrin and MAP3K1 were significantly up-regulated in pancreatic tumours compared to healthy tissue and high expression of these genes correlated with reduced survival of pancreatic cancer patients. This evidence concerns the gene MAP3K1 and familial pancreatic carcinoma.